Other
Carotid Endarterectomy
0
Pipeline Programs↗
0
Active Trials↗
2
Companies Involved↗
Carotid Endarterectomy is an early-stage landscape with 0 programs across 2 companies. The most active players are Tallikut Pharmaceuticals, Inc., GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed10 · 71%
Unknown status2 · 14%
Withdrawn1 · 7%
Terminated1 · 7%
Clinical Trials
Trial Activity
14 trials
Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes
Completed·—·Phase 3·NCT02850081·31 enrolled
Effects of Vasopressors on Cerebral Hemodynamics in Patients With Carotid Endarterectomy (TCD Part)
Completed·—·N/A·NCT05665881·90 enrolled
Effect on Cerebral Oxygenation by Sevoflurane or Propofol Using Near-infrared Spectroscopy in Carotid Endarterectomy
Completed·—·Phase 4·NCT02609087·69 enrolled
Evaluation of Brain Damage Resulting From Carotid Endarterectomy With Xenon Anesthesia
Completed·—·N/A·NCT01404819·86 enrolled
A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
Withdrawn·—·Phase 2·NCT00401921
Effects of Vasopressors on Cerebral Hemodynamics in Patients With Carotid Endarterectomy (MRI Part)
Unknown status·—·N/A·NCT05414877·60 enrolled
Effect of Blood Pressure on rSO2 in Carotid Endarterectomy (CEA)
Unknown status·—·N/A·NCT01451294·40 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)